Biomarin Pharmaceutical (BMRN) Q4 2018 Earnings

25OctConfirmed
Q1 2018
Q2 2018
Q3 2018
Q4 2018
-0.4
-0.29
-0.18
-0.07

Details

Expected EPS
-0.21
Actual EPS
-0.07
Surprise EPS
0.14
Surprise Percent
+66.67%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.07 per share for Q4 2018.

0 Comments

Share your thoughts